1) Onty has no money on hand (several hundred millions are no $$?);
2) Stimuvax is dead (all trials with Stimuvax continue and tons of money are wasted cause Merck Kgaa is a drunken sailor, and the market has discounted this pony for zero worth;
3) PX866 phII trials are worthy something, are they? Although one cannot compare bit by bit, it is shown that Infinity Pharmaceuticals, Inc. (INFI) with the same class of drug in phase I trials has a market cap of well over 1.3 billion, listen, it is billions not millions:
4) The old timers except a few like me have all sold and now stand in the line of bears.
At least, I don't need to watch this pony every day.